GRIA2 and early-onset autosomal dominant Alzheimer disease: The emerging role of the PICK1-GluA2 interaction in synaptic biology prompted us to search for small molecule inhibitors of this protein-protein interaction to stabilize AMPA receptors on the cell surface and promote synaptic structure and function as a potential treatment for Alzheimer’s disease.